CD8A and neoplasm: Woosook et al. used oxaliplatin and 5-fluorouracil in a murine model of GC to show that 5-fluorouracil and oxaliplatin may reduce the number of myeloid-derived suppressor cells (MDSC), synergise with pembrolizumab, and promote CD8+ T cell tumour infiltration [24].